Related Experiment Videos

Analysis of a clinical trial involving a combined mortality and adherence dependent interval censored endpoint

L A Moyé1, B R Davis, C M Hawkins

  • 1University of Texas Health Science Center, Houston 77025.

Statistics in Medicine
|September 30, 1992
PubMed

Insights

Analyzing combined clinical trial endpoints with mixed censoring is challenging. This study introduces a novel rank-based statistic to effectively analyze these complex time-to-event measures, enhancing statistical power.

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Statistical Analysis

Background:

  • Clinical trials frequently utilize combined endpoints, merging multiple measures for comprehensive assessment.
  • Analysis of combined time-to-event endpoints is standard when both components are regularly measured.
  • Challenges arise when one component is right-censored and the other is interval-censored.

Purpose of the Study:

  • To develop and evaluate a statistical method for analyzing combined time-to-event endpoints with mixed censoring.
  • To address the analytical difficulties posed by right-censored and interval-censored data within a single endpoint.

Main Methods:

  • A novel test statistic is proposed, based on the rank ordering of events for the combined endpoint.
  • The statistical power of the developed test statistic is explored and evaluated.

Main Results:

  • The paper introduces a new rank-based statistic for analyzing combined endpoints with mixed censoring.
  • The study investigates the power of this novel statistical approach.

Conclusions:

  • The proposed rank-based statistic offers a viable method for analyzing complex combined endpoints in clinical trials.
  • This approach can improve the statistical rigor and power when dealing with mixed right and interval censoring.

Related Concept Videos